Navigation Links
Future MRSA Outbreaks in Schools are Preventable!

Skinvisible's Antibacterial Hand Sanitizer Lotion Kills MRSA on Contact

LAS VEGAS, Oct. 22 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI) (Website: has formulated a product that may have stopped the recent spread of the Super-Bug, MRSA (methicillin-resistant Staphylococcus aureus) in schools and universities. The product, a non-alcohol based antibacterial hand sanitizer lotion made with Invisicare(R), is marketed by Triple-S under the brand name Protec-4(TM).


Recent headlines have indicated that MRSA is more prevalent than ever, even outside of the hospital environment. According to The Journal of the American Medical Association, October 17, 2007 "... such infections may be twice as common as previously thought, according to its lead author, Dr. R. Monina Klevens. If the mortality estimates are correct, the number of deaths associated with the germ, methicillin-resistant Staphylococcus aureus, or MRSA, would exceed those attributed to H.I.V.-AIDS, Parkinson's disease, emphysema or homicide each year."

Preventative measures are available. Independent studies verify that Protec-4 effectively kills MRSA as well as other common bacteria on contact. According to Ken Crutcher, Member and Board Director of Triple S, school systems from New York to Kentucky are installing Protec-4 to keep their students and staff healthy. "The Union County Board of Education in Morganfield, KY. has been proactive about stopping the spread of MRSA in their school system. Their strategy starts with having each student apply Protec-4 when getting on the school bus (bus riders cover 75% of the student population). Secondly every teacher's desk has a bottle of Protec-4 and the students are required to use it first thing in the morning and again at lunch. Support and maintenance staff also have Protec-4 available for their use," said Mr. Crutcher. He further commented, "Another school system recently conducted an in-school study that showed their pupils actually preferred the Protec-4 hand sanitizing lotion over alcohol-based sanitizers which tend to dry out the skin following repeated uses. They installed Protec-4 dispensing systems in over 300 class rooms."

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals, a wholly owned subsidiary of Skinvisible Inc., is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products. AND

About Triple S

Based in Billerica, Massachusetts, Triple S is a national distribution, networking, sales, marketing and logistics organization in the janitorial and sanitary supply industry. With 115 Member-dealers and four regional distribution centers across the United States, Triple S offers nationwide service to the education, health care, commercial, industrial, and government markets.

About Protec-4(TM)

Clean hands are paramount to reducing the spread of MRSA. Protec-4 Hand Sanitizing Lotion is effective against a broad spectrum of pathogens including MRSA, e-coli, Listeria, Salmonella, Strep, Staph, VRE and more. Protec-4 kills 99.9% of harmful germs. Protec-4 Hand Sanitizing Lotion is available in 8 oz. pump bottles (8/case) and a 500 mL. controlled dispensing system.

Forward-Looking Statements

This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending June 30, 2007).

Corporate Contact:

Terry Howlett, President/CEO

Skinvisible Pharmaceuticals, Inc

Phone: 702-433-7154


SOURCE Skinvisible, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Low Birth Weight infants could have Problems in the Future
2. Eyes,The Window To The Future
3. Needle free future for diabetics
4. Oral memory indicates future Alzheimers patients
5. New Virus : A Threat In the Future?
6. Will Your Baby Grow Up To Be A Future Einstein ?
7. Genetic Pills A Future Thought
8. Prediction Of Disease In The Future Questioned
9. Asthmatics May Be At Risk for Lung Disease In The Future
10. Use Of Sunscreen In Childhood And Prevents Future Skin Cancer
11. Childrens Waistlines A Predictor Of Future Heart Disease
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android app ... new app features a more intuitive SleepScore™ that rates sleep quality on a 100-point ... SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide an ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
(Date:11/25/2015)... ... , ... Today, Mothers Against Drunk Driving (MADD) learned that the ... the first time since 2011. In 2014, there were 9,967 fatalities involving an alcohol ... National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development ... expansion of its current state of the art research, development and manufacturing facility ... increase its manufacturing capacity as well as to support its clients’ growing research ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Endo International ... Rajiv De Silva , President and CEO, will discuss ... Healthcare Conference in New York on ... . Click on Investor Relations, and then the ... prior to the presentation,s start time to visit the site ...
Breaking Medicine Technology: